Philip Morris International Inc. (4PM.TI)
| Previous close | 109.74 |
| Open | 109.10 |
| Bid | 107.32 x N/A |
| Ask | 107.46 x N/A |
| Day's range | 109.10 - 109.10 |
| 52-week range | 81.00 - 115.52 |
| Volume | |
| Avg. volume | 25 |
| Market cap | N/A |
| Beta (5Y monthly) | 0.58 |
| PE ratio (TTM) | N/A |
| EPS (TTM) | N/A |
| Earnings date | N/A |
| Forward dividend & yield | N/A (N/A) |
| Ex-dividend date | N/A |
| 1y target est | N/A |
- The Telegraph
Cigarette maker sells British inhaler business after backlash
Marlboro cigarette maker Philip Morris has been forced to sell a British maker of asthma inhalers at a steep loss after a growing backlash from health groups opposed to its ownership.
- Reuters
Philip Morris to sell Vectura for $198 million after health shift criticism
Marlboro maker PMI bought Vectura in September 2021 as part of a plan to transform itself into a "broader healthcare and wellness" group, a shift it says has been hampered by critics. PMI acquired Vectura, part of its health and wellness unit, in a deal worth 1.1 billion pounds.
- Insider Monkey
Here’s Why Philip Morris International (PM) Gained in Q2
Broyhill Asset Management, an investment management company, released a second-quarter 2024, investor letter. A copy of the letter can be downloaded here. Despite gains in global markets, the Broyhill Equity portfolio declined in the second quarter. As the gap in market leadership grew, the fund underperformed. That doesn’t make it any easier to take and […]
